Company: HCTI
Filing Date: 2025-05-15
Form Type: 424B4
Source: 0001213900-25-044095
Chunk: 2

Company: Healthcare Triangle, Inc.
Filing Date: 2025-05-15
Form: 424B4
Chunk 2
---
 to up to 30 shares of common stock
underlying each Series B Warrant if the exercise price decreases to and equals the Floor Price at the time of such election. As such,
holders of the Series B Warrants may elect to be issued up to 1,085,714,550 shares of common stock upon the exercise of the Series B
Warrants assuming the Floor Price. For a description of the risks involved with exercise of the Series B Warrants, see “Risk Factors—Risks
Related to this Offering.”

The shares of Common Stock
covered by this prospectus have been or will be issued in reliance on exemptions from registration provided by Section 4(a)(2) of the
Securities Act, and Rule 506(b) promulgated thereunder. We are registering the shares of Common Stock to satisfy our obligations in connection
with registration rights we have granted to the selling stockholders pursuant to the terms of a Registration Rights Agreement, dated as
of February 28, 2025, by and between the Company and the selling stockholders (the “Registration Rights Agreement”).

We are not selling any shares
of our Common Stock in this offering and we will not receive any of the proceeds from the sale of shares of our Common Stock by the selling
stockholder. The selling stockholders will receive all of the proceeds from any sales of the shares of our Common Stock offered hereby,
but we will receive the proceeds from any cash exercises of the Purchase Warrants. However, we will incur expenses in connection with
the registration of the shares of our Common Stock offered hereby.

The
selling stockholders may sell these shares through public or private transactions at market prices prevailing at the time of sale or at
negotiated prices. The timing and amount of any sale are within the sole discretion of each selling stockholder. The selling stockholders
and any underwriters, dealers or agents that participate in distribution of the securities may be deemed to be underwriters, and any profit
on sale of the securities by them and any discounts, commissions or concessions received by any underwriter, dealer or agent may be deemed
to be underwriting discounts and commissions under the Securities Act. There can be no assurances that the selling stockholders will sell
any or all of the securities offered under this prospectus.

For
further information regarding the possible methods by which the shares may be distributed, see the section titled “Plan of Distribution” beginning on page 15 of this prospectus. We will bear all costs,